SEC Form 4 · accession 0001209191-15-009065
SYNAPTICS Inc · SYNA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kathleen A Bayless
Officer — SVP, CFO, & Treasurer
Period of report
Jan 30, 2015
Accepted (ET)
Feb 3, 2015 · 6:11 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000817720
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Feb 2, 2015 | M | 1,625 | $37.20 | A | 19,582 | D | |
| Common StockF1,F2 | Feb 2, 2015 | M | 2,065 | $39.80 | A | 21,647 | D | |
| Common StockF1,F2 | Feb 2, 2015 | M | 1,310 | $61.40 | A | 22,957 | D | |
| Common StockF4,F1,F2 | Feb 2, 2015 | S | 5,000 | $75.0748 | D | 17,957 | D | |
| Common StockF5,F1,F2 | Feb 2, 2015 | F | 312 | $77.88 | D | 17,645 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F6 | $76.81 | Jan 30, 2015 | A | 3,000 | A | — | Jan 30, 2022 | Common Stock | 3,000 | 3,000 | D |
| Employee Stock Option (Right to Buy)F7 | $37.20 | Feb 2, 2015 | M | 1,625 | D | — | Jan 30, 2019 | Common Stock | 1,625 | 17,125 | D |
| Employee Stock Option (Right to Buy)F8 | $39.80 | Feb 2, 2015 | M | 2,065 | D | — | Aug 5, 2020 | Common Stock | 2,065 | 2,310 | D |
| Employee Stock Option (Right to Buy)F9 | $61.40 | Feb 2, 2015 | M | 1,310 | D | — | Apr 28, 2021 | Common Stock | 1,310 | 3,930 | D |
Explanation of responses
- F1Includes 402 shares acquired under the Issuer's employee stock purchase plan in November 2014, but not previously reported.
- F2The amount of securities beneficially owned by the reporting person on the reporting person's previous Form 4 erroneously included an additional 4,300 shares.
- F3The shares were sold pursuant to a 10b5-1 Sales Plan dated August 19, 2014.
- F4The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.01 to $75.275, inclusive. The reporting person undertakes to provide to Synaptics Incorporated (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
- F5Represents shares of common stock withheld by the Issuer to satisfy certain tax withholding obligations associated with the vesting of deferred stock units.
- F61/12th of the total number of shares subject to the option shall vest and become exercisable each quarter following the January 30, 2015 date of grant, until fully vested on January 30, 2018.
- F71/48th of the total number of shares subject to the option vested or shall vest and became or shall become exercisable on the 30th day of each month following the January 30, 2012 date of grant, until fully vested on January 30, 2016.
- F81/36th of the total number of shares subject to the option vested or shall vest and became or shall become exercisable on the 5th day of each month following the August 5, 2013 date of grant, until fully vested on August 5, 2016.
- F91/12th of the total number of shares subject to the option vested or shall vest and became or shall become exercisable each quarter following the April 28, 2014 date of grant, until fully vested on April 28, 2017.